Results 121 to 130 of about 79,111 (213)

Onset of Hyperkalemia following the Administration of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker. [PDF]

Cardiovasc Ther, 2021
Jun HR, Kim H, Lee SH, Cho JH, Lee H, Yim HW, Yoon KH, Kim HS.   +7 more
europepmc   +1 more source

Azilsartan alone and in combination for the treatment of hypertension – clinical utility and patient considerations

Research Reports in Clinical Cardiology, 2013
Jocelyn D Jones,1 Sylvia H Jackson,1 Charlie Colquitt21College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Jacksonville, FL, USA; 2College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Tampa, FL ...
Jones JD, Jackson SH, Colquitt C
doaj  

Angiotensin II receptor blocker intake associates with reduced markers of inflammatory activation and decreased mortality in patients with cardiovascular comorbidities and COVID-19 disease. [PDF]

PLoS One, 2021
Cremer S, Pilgram L, Berkowitsch A, Stecher M, Rieg S, Shumliakivska M, Bojkova D, Wagner JUG, Aslan GS, Spinner C, Luxán G, Hanses F, Dolff S, Piepel C, Ruppert C, Guenther A, Rüthrich MM, Vehreschild JJ, Wille K, Haselberger M, Heuzeroth H, Hansen A, Eschenhagen T, Cinatl J, Ciesek S, Dimmeler S, Borgmann S, Zeiher A, LEOSS study group.   +28 more
europepmc   +1 more source

Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and coronavirus

Journal of Hypertension, 2020
Verdecchia, Paolo, Angeli, Fabio, Reboldi, Gianpaolo   +2 more
openaire   +4 more sources

New standards in hypertension and cardiovascular risk management: focus on telmisartan

Vascular Health and Risk Management, 2010
Domenico Galzerano1, Cristina Capogrosso4, Sara Di Michele2, Antonio Galzerano1, Paola Paparello1, Diana Lama3, Carlo Gaudio21Department of Cardiology, San Gennaro Hospital, Naples, Italy; 2Department of Heart and Great Vessels, A.
Domenico Galzerano, Cristina Capogrosso, Sara Di Michele, et al   +3 more
doaj  

Correction: Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans. [PDF]

PLoS One, 2021
PLOS ONE Staff.
europepmc   +1 more source

Effect of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker on the patients with sepsis. [PDF]

Korean J Intern Med, 2021
Lee HW, Suh JK, Jang E, Lee SM.
europepmc   +1 more source

Losartan associated anaphylaxis and angioneurotic oedema [PDF]

, 2010
A case of anaphylaxis and angioedema induced by angiotensin II receptor blocker (ARB), losartan is reported. A 37 years old hypertensive female presented to the Emergency Department with swelling over the face especially the lips, urticarial rash all ...
Kazim, Syed Faraz, Shahid, Muhammad
core   +1 more source

The Angiotensin II Receptor Blocker Losartan Sensitizes Human Liver Cancer Cells to Lenvatinib-Mediated Cytostatic and Angiostatic Effects. [PDF]

Cells, 2021
Takagi H, Kaji K, Nishimura N, Ishida K, Ogawa H, Takaya H, Kawaratani H, Moriya K, Namisaki T, Akahane T, Mitoro A, Yoshiji H.   +11 more
europepmc   +1 more source

Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans. [PDF]

PLoS One, 2021
Derington CG, Cohen JB, Mohanty AF, Greene TH, Cook J, Ying J, Wei G, Herrick JS, Stevens VW, Jones BE, Wang L, Zheutlin AR, South AM, Hanff TC, Smith SM, Cooper-DeHoff RM, King JB, Alexander GC, Berlowitz DR, Ahmad FS, Penrod MJ, Hess R, Conroy MB, Fang JC, Rubin MA, Beddhu S, Cheung AK, Xian W, Weintraub WS, Bress AP.   +29 more
europepmc   +1 more source